References
- Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967: 17(5): 427–42
- Ward CD, Duvoisin RC, Ince SE, et al. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 1983: 33(7): 815–24
- Tanner CM. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci 1989: 12(2): 49–54
- Aminoff MJ. Parkinsonism. In: Schroeder SA, Krupp MA, Tierney LM, et al, eds. Current medical diagnosis and treatment. East Norwalk, CT: Appleton & Lange, 1990: 663–6
- Cleeves L, Findley LJ. Tremors. Med Clin North Am 1989: 73(6): 1307–19
- Mahlon DR, Gordon B, Randol B. Common disorders of movement: tremor and Parkinson's disease. In: Barker LR, Burton JR, Zieve PD, eds. Principles of ambulatory medicine. Baltimore: Williams & Wilkins, 1986: 1173–85
- Fahn S. Parkinsonism. In: Wyngaarden JB, Smith LH Jr, eds. Cecil's textbook of medicine. 18 th ed. Philadelphia: WB Saunders, 1988: 2143–7
- Hakim AM, Mathieson G. Dementia in Parkinson disease: a neuropathologic study. Neurology 1979: 29(9 Pt 1): 1209–14
- Mindham RH. Psychiatric aspects of Parkinson's disease. Br J Hosp Med 1974: 3(3): 411–7
- Brooks DJ, Frackowiak RS. PET and movement disorders. J Neurol Neurosurg Psychiatry 1989: 52(Suppl): 68–77
- Ahlskog JE. Medical treatment of Parkinson's disease. Compr Ther 1989: 15(3): 53–9
- Boshes B. Sinemet and the treatment of Parkinsonism. Ann Intern Med 1981: 94(3): 364–70
- Marsden CD. Parkinson's disease. Lancet 1990: 335(8695): 948–52
- Ahlskog JE, Muenter MD. Treatment of Parkinson's disease with pergolide: a double-blind study. Mayo Clin Proc 1988: 63(10): 969–78
- Lieberman AN. Treatment of Parkinson's disease. Mayo Clin Proc 1988: 63(10): 1046–9
- Asnis G. Parkinson's disease, depression, and ECT: a review and case study. Am J Psychiatry 1977: 134(2): 191–5
- Douyon R, Serby M, Klutchko B, et al. ECT and Parkinson's disease revisited: a “naturalistic” study. Am J Psychiatry 1989: 146(11): 1451–5
- Atre-Vaidya N, Jampala VC. Electroconvulsive therapy in parkinsonism with affective disorder. Br J Psychiatry 1988: 152(1): 55–8
- Birkmayer W, Riederer P, Youdim MB, et al. The potentiation of the antiakinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenyl. J Neural Transm 1975: 36(3–4): 303–26
- Elizan TS, Moros DA, Yahr MD. Early combination of selegiline and low-dose levodopa as initial symptomatic therapy in Parkinson's disease: experience in 26 patients receiving combined therapy for 26 months. Arch Neurol 1991: 48(1): 31–4
- The Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989: 321 (20): 1364–71
- Sladek JR Jr, Gash DM. Nerve-cell grafting in Parkinson's disease. J Neurosurg 1988: 68(3): 337–51
- Madrazo I, Drucker-Colin R, Diaz V, et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 1987: 316(14): 831–4
- Goetz CG, Olanow CW, Koller WC, et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 1989: 320(6): 337–41